Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(2)
•••
Comment by Safetyinnumberson May 03, 2019 12:17am
145 Views
Post# 29704781

RE:RE:RE:RE:RE:Financials anyone?

RE:RE:RE:RE:RE:Financials anyone?Yes, I saw that but it wasn’t consistent with the other wording that the auditor resigned, nor with the PR
Raza Bohkari. “It is important that UHY, our new auditor appointed in April 2019 for reasons outside of our control
Read more at https://stockhouse.com/news/press-releases/2019/05/02/fsd-pharma-provides-update-on-status-of-2018-year-end-filings#kgLblCeLUHx5USdF.99

I think some clarity here, especially where prior financials were unaudited, a new auditor comes in nand then resigns
If someone is terminated that is one thing-why not say that
Anywasy, the lack of disclosure, other than what I found scanning SEDAR, is consistent with the approach so far

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities